Testing effectiveness (Phase 2)UnknownNCT04915300What this trial is testingApabetalone for Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Laval University 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511What this trial is testingOral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionWho this might be right forScleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more Cumberland Pharmaceuticals 34
Large-scale testing (Phase 3)Active Not RecruitingNCT04175600What this trial is testingSelexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial HypertensionWho this might be right forHypertension, Pulmonary Actelion 138
Testing effectiveness (Phase 2)Ended earlyNCT02736149What this trial is testingOpen-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)Who this might be right forPulmonary Arterial Hypertension Eiger BioPharmaceuticals 51
Testing effectiveness (Phase 2)Ended earlyNCT00832507What this trial is testingStudy of Cicletanine for Pulmonary Arterial Hypertension (PAH)Who this might be right forPulmonary Arterial Hypertension Gilead Sciences 162
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07441200What this trial is testingClinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)Who this might be right forPulmonary Arterial Hypertension NS Pharma, Inc. 135
Testing effectiveness (Phase 2)Study completedNCT03638908What this trial is testingFluoxetine in Pulmonary Arterial Hypertension (PAH) TrialWho this might be right forPulmonary Arterial Hypertension University of Texas Southwestern Medical Center 8
Not applicableStudy completedNCT03077386What this trial is testingEnhancing Community Health Through Patient Navigation, Advocacy and Social SupportWho this might be right forHypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more University of Calgary 176
Testing effectiveness (Phase 2)Ended earlyNCT03449524What this trial is testingPRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)Who this might be right forPAH Complexa, Inc. 69
Large-scale testing (Phase 3)Study completedNCT00091598What this trial is testingARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)Who this might be right forPulmonary Hypertension Gilead Sciences 372
Testing effectiveness (Phase 2)Ended earlyNCT01725269What this trial is testingLong-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05Who this might be right forPulmonary Arterial Hypertension Aires Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT06137742What this trial is testingLearn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Pfizer 97
Early research (Phase 1)Study completedNCT05567367What this trial is testingA Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234Who this might be right forHealthy Volunteer Respira Therapeutics, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT01265888What this trial is testingStudy in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.Who this might be right forPulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis Geno LLC 31
Testing effectiveness (Phase 2)Study completedNCT01457781What this trial is testingInhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)Who this might be right forPulmonary Arterial HypertensionPulmonary Hypertension Bellerophon Pulse Technologies 80
Testing effectiveness (Phase 2)Looking for participantsNCT05587712What this trial is testingStudy to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)Who this might be right forPulmonary Arterial Hypertension Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)Ended earlyNCT04125745What this trial is testingOral CXA-10 in Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Gladwin, Mark, MD 1
Large-scale testing (Phase 3)Study completedNCT00810693What this trial is testingEvaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)Who this might be right forPulmonary Hypertension Bayer 445
Testing effectiveness (Phase 2)WithdrawnNCT03789643What this trial is testingStudy to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Akros Pharma Inc.
Testing effectiveness (Phase 2)WithdrawnNCT06643143What this trial is testingIkT-001Pro in Pulmonary Arterial Hypertension (PAH)Who this might be right forPulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) Inhibikase Therapeutics